Marcia Bellon

2.1k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

Marcia Bellon is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Molecular Biology. According to data from OpenAlex, Marcia Bellon has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 13 papers in Ecology, Evolution, Behavior and Systematics and 12 papers in Molecular Biology. Recurrent topics in Marcia Bellon's work include T-cell and Retrovirus Studies (23 papers), Vector-Borne Animal Diseases (13 papers) and Animal Disease Management and Epidemiology (9 papers). Marcia Bellon is often cited by papers focused on T-cell and Retrovirus Studies (23 papers), Vector-Borne Animal Diseases (13 papers) and Animal Disease Management and Epidemiology (9 papers). Marcia Bellon collaborates with scholars based in United States, France and China. Marcia Bellon's co-authors include Christophe Nicot, Chien‐Hung Yeh, Olivier Hermine, Yves Lepelletier, Megan Brown, Hicham H. Baydoun, Abhik Datta, Yuan Yao, Joanna Pancewicz and Ramona Moles and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Marcia Bellon

28 papers receiving 1.6k citations

Hit Papers

FBXW7: a critical tumor s... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcia Bellon United States 20 799 575 295 289 280 28 1.6k
Takayuki Ohshima Japan 21 1.0k 1.3× 372 0.6× 240 0.8× 194 0.7× 198 0.7× 45 1.7k
Nanae Harashima Japan 27 752 0.9× 982 1.7× 561 1.9× 265 0.9× 261 0.9× 48 1.8k
Nicole S. Harhaj United States 14 745 0.9× 749 1.3× 189 0.6× 204 0.7× 211 0.8× 15 1.8k
Noula Shembade United States 16 831 1.0× 1.1k 1.9× 275 0.9× 170 0.6× 173 0.6× 25 1.8k
Naomichi Arima Japan 23 305 0.4× 859 1.5× 190 0.6× 493 1.7× 410 1.5× 96 1.5k
Meztli Arguello Canada 16 958 1.2× 884 1.5× 355 1.2× 66 0.2× 69 0.2× 20 1.9k
Xuefeng Wu United States 25 1.2k 1.5× 953 1.7× 445 1.5× 44 0.2× 61 0.2× 42 2.0k
Suzana Marušić United States 17 495 0.6× 789 1.4× 235 0.8× 30 0.1× 63 0.2× 26 1.5k
Simon T. Whiteside France 15 1.4k 1.7× 1.4k 2.5× 560 1.9× 77 0.3× 110 0.4× 17 2.6k

Countries citing papers authored by Marcia Bellon

Since Specialization
Citations

This map shows the geographic impact of Marcia Bellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcia Bellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcia Bellon more than expected).

Fields of papers citing papers by Marcia Bellon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcia Bellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcia Bellon. The network helps show where Marcia Bellon may publish in the future.

Co-authorship network of co-authors of Marcia Bellon

This figure shows the co-authorship network connecting the top 25 collaborators of Marcia Bellon. A scholar is included among the top collaborators of Marcia Bellon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcia Bellon. Marcia Bellon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellon, Marcia & Christophe Nicot. (2024). HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation. Pathogens. 13(1). 87–87. 10 indexed citations
2.
Bellon, Marcia, et al.. (2024). The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7. Journal of Virology. 98(7). e0040524–e0040524. 5 indexed citations
3.
Bellon, Marcia & Christophe Nicot. (2023). Targeting Pim kinases in hematological cancers: molecular and clinical review. Molecular Cancer. 22(1). 18–18. 45 indexed citations
4.
Fan, Jingyi, Marcia Bellon, Mingyi Ju, et al.. (2022). Clinical significance of FBXW7 loss of function in human cancers. Molecular Cancer. 21(1). 87–87. 89 indexed citations
5.
Bellon, Marcia, Izabela Bialuk, Veronica Galli, et al.. (2021). Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases. Molecular Cancer. 20(1). 86–86. 9 indexed citations
6.
Yeh, Chien‐Hung, Marcia Bellon, Fang Wang, et al.. (2020). Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells. Molecular Cancer. 19(1). 139–139. 23 indexed citations
7.
Yeh, Chien‐Hung, Marcia Bellon, & Christophe Nicot. (2018). FBXW7: a critical tumor suppressor of human cancers. Molecular Cancer. 17(1). 115–115. 367 indexed citations breakdown →
8.
Bellon, Marcia, et al.. (2018). JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells. Journal of Hematology & Oncology. 11(1). 119–119. 19 indexed citations
9.
Bellon, Marcia & Christophe Nicot. (2017). Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection. Viruses. 9(10). 289–289. 106 indexed citations
10.
Bellon, Marcia, Ling Lü, & Christophe Nicot. (2016). Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia. Blood. 127(20). 2439–2450. 44 indexed citations
11.
Moles, Ramona, Marcia Bellon, & Christophe Nicot. (2015). STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I–Transformed and ATL Cells. Neoplasia. 17(5). 449–462. 50 indexed citations
12.
Lemaçon, Delphine, Hélène Fontaine, Marcia Bellon, et al.. (2014). Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions. Molecular Cancer. 13(1). 205–205. 27 indexed citations
13.
Bellon, Marcia, Nga Ling Ko, Min-Jung Lee, et al.. (2013). Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation. Blood. 121(25). 5045–5054. 31 indexed citations
14.
Bai, Xue, Uma Sinha-Datta, Nga Ling Ko, Marcia Bellon, & Christophe Nicot. (2012). Nuclear Export and Expression of Human T-Cell Leukemia Virus Type 1 tax / rex mRNA Are RxRE/Rex Dependent. Journal of Virology. 86(8). 4559–4565. 16 indexed citations
15.
Yao, Yuan, Marcia Bellon, Shary N. Shelton, & Christophe Nicot. (2012). Tumor Suppressors p53, p63TAα, p63TAy, p73α, and p73β Use Distinct Pathways to Repress Telomerase Expression. Journal of Biological Chemistry. 287(24). 20737–20747. 13 indexed citations
16.
Bellon, Marcia, Hicham H. Baydoun, Yuan Yao, & Christophe Nicot. (2010). HTLV-I Tax-dependent and -independent events associated with immortalization of human primary T lymphocytes. Blood. 115(12). 2441–2448. 55 indexed citations
17.
Bellon, Marcia, Yves Lepelletier, Olivier Hermine, & Christophe Nicot. (2009). Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood. 113(20). 4914–4917. 128 indexed citations
18.
Bellon, Marcia & Christophe Nicot. (2008). Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control. JNCI Journal of the National Cancer Institute. 100(2). 98–108. 79 indexed citations
19.
Bellon, Marcia & Christophe Nicot. (2007). Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia.. PubMed. 4(1). 21–5. 7 indexed citations
20.
Datta, Abhik, Marcia Bellon, Uma Sinha-Datta, et al.. (2006). Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood. 108(3). 1021–1029. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026